Physiological consequences of antiserum-mediated experimental demyelination in CNS
- PMID: 3382916
- DOI: 10.1093/brain/111.3.675
Physiological consequences of antiserum-mediated experimental demyelination in CNS
Abstract
To study the pathophysiology of immunologically mediated demyelination in the central nervous system (CNS), we injected 20 to 30 microliters of polyclonal antigalactocerebroside serum (AGC) into the lower thoracic dorsal column of the spinal cord in 20 Wistar rats. AGC-injected spinal cords contained areas of fascicular demyelination adjacent to the focus of axonal degeneration at the injection site. Somatosensory evoked potentials were recorded serially after tibial nerve stimulation. In 85% of AGC-injected animals, the following characteristics were observed by 3 days after injection: (1) decreased amplitude of the cortically generated potential (P15); (2) failure of transmission of high-frequency (50 Hz) impulses (rate-dependent block); (3) delayed conduction velocity of the compound action potentials through the lesion. None of these changes was seen in 90% of 20 rats injected with normal saline or control rabbit sera. In 7 rats with acrylamide-induced axonopathy or wallerian degeneration, the rate-dependent block was not observed. The onset of clinical symptoms (hindlimb ataxia) in AGC-injected rats was best correlated with development of the rate-dependent block. Clinical recovery was observed by 14 days after injection concurrent with restoration of P15 amplitude, when the rate-dependent block and decreased conduction velocities were unchanged. High-frequency-resistant conduction was re-established much later than clinical recovery in 3 rats. These findings suggest that failure of high-frequency impulse transmission may produce clinical symptoms and that a central adaptive mechanism to remodulated trains of impulses plays a role in clinical recovery from CNS demyelination.
Similar articles
-
Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve.Ann Neurol. 1982 May;11(5):469-77. doi: 10.1002/ana.410110506. Ann Neurol. 1982. PMID: 6285800
-
Antiserum-mediated demyelination: relationship between remyelination and functional recovery.Ann Neurol. 1980 Jul;8(1):12-24. doi: 10.1002/ana.410080103. Ann Neurol. 1980. PMID: 7406444
-
The pathophysiology of chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.Brain. 1991 Aug;114 ( Pt 4):1827-53. doi: 10.1093/brain/114.4.1827. Brain. 1991. PMID: 1884181
-
Consequences of peripheral nerve demyelination: basic and clinical aspects.Can J Neurol Sci. 1993 Nov;20(4):263-70. Can J Neurol Sci. 1993. PMID: 8313241 Review.
-
[Physiological approach to peripheral neuropathy. Conventional nerve conduction studies and magnetic motor root stimulation].Rinsho Shinkeigaku. 2004 Nov;44(11):986-90. Rinsho Shinkeigaku. 2004. PMID: 15651350 Review. Japanese.
Cited by
-
The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1649-73. doi: 10.1098/rstb.1999.0510. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603618 Free PMC article. Review.
-
Electrophysiological follow-up of acute and chronic experimental allergic encephalomyelitis in the Lewis rat.Eur Arch Psychiatry Clin Neurosci. 1992;242(1):1-5. doi: 10.1007/BF02190335. Eur Arch Psychiatry Clin Neurosci. 1992. PMID: 1390949
-
Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis.Glia. 2022 Oct;70(10):1950-1970. doi: 10.1002/glia.24231. Epub 2022 Jul 9. Glia. 2022. PMID: 35809238 Free PMC article.
-
Conduction in segmentally demyelinated mammalian central axons.J Neurosci. 1997 Oct 1;17(19):7267-77. doi: 10.1523/JNEUROSCI.17-19-07267.1997. J Neurosci. 1997. PMID: 9295373 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources